Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|23|1|8-21

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.23, Iss.1, 2006-10, pp. : 8-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer’s Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 3, 2009-02 ,pp. : 232-239

Karger

Access to resources Recommend Favorite

Long-Term Statin Therapy and CSF Cholesterol Levels: Implications for Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 6, 2009-05 ,pp. : 519-524

Karger

Access to resources Recommend Favorite

Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 6, 2000-10 ,pp. : 299-313

Karger

Access to resources Recommend Favorite

Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey

By  

Digestive Diseases, Vol. 35, Iss. 5, 2017-06 ,pp. : 423-432

Karger

Access to resources Recommend Favorite

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 163-179

Karger

Access to resources Recommend Favorite